Your browser doesn't support javascript.
loading
Stakeholder perspectives on addressing adverse events from adjuvant cancer therapy: A qualitative study.
Pettit, Syril D; Silberman, Pamela; Hassmiller Lich, Kristen; Kirch, Rebecca A; Lipshultz, Steven E; Teal, Randall; Basch, Ethan.
Afiliação
  • Pettit SD; Health Policy and Management, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina.
  • Silberman P; Health and Environmental Sciences Institute, Washington, DC.
  • Hassmiller Lich K; Health Policy and Management, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina.
  • Kirch RA; Health Policy and Management, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina.
  • Lipshultz SE; National Patient Advocate Foundation, Washington, DC.
  • Teal R; Department of Pediatrics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, New York.
  • Basch E; Connected Health for Applications & Interventions (CHAI) Core, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Cancer ; 125(24): 4471-4480, 2019 Dec 15.
Article em En | MEDLINE | ID: mdl-31454424
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quimioterapia Adjuvante / Neoplasias Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quimioterapia Adjuvante / Neoplasias Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article